Anastassia Negrouk

664 total citations
23 papers, 212 citations indexed

About

Anastassia Negrouk is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Cancer Research. According to data from OpenAlex, Anastassia Negrouk has authored 23 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 9 papers in Economics and Econometrics and 9 papers in Cancer Research. Recurrent topics in Anastassia Negrouk's work include Cancer Genomics and Diagnostics (9 papers), Ethics in Clinical Research (8 papers) and Biomedical Ethics and Regulation (7 papers). Anastassia Negrouk is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Ethics in Clinical Research (8 papers) and Biomedical Ethics and Regulation (7 papers). Anastassia Negrouk collaborates with scholars based in Belgium, United Kingdom and Italy. Anastassia Negrouk's co-authors include Denis Lacombe, Michel Seymour, Kate Law, Ted Trimble, Françoise Meunier, Peter Hoskin, J. Kalmus, Isabelle Huys, Christiane De Wolf‐Peeters and Houchingue Eghbali and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Anastassia Negrouk

21 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anastassia Negrouk Belgium 8 74 68 54 44 39 23 212
Gillian M. Belbin United States 13 40 0.5× 56 0.8× 32 0.6× 14 0.3× 49 1.3× 24 442
Dorte Tholstrup Denmark 6 180 2.4× 63 0.9× 55 1.0× 9 0.2× 60 1.5× 10 303
John Marquart United States 5 93 1.3× 27 0.4× 27 0.5× 41 0.9× 105 2.7× 11 285
Rashid Ramezani Iran 6 144 1.9× 17 0.3× 47 0.9× 13 0.3× 33 0.8× 12 323
G. P. Summerfield United Kingdom 11 36 0.5× 55 0.8× 28 0.5× 17 0.4× 15 0.4× 21 304
Eugenio Vinés Chile 6 208 2.8× 42 0.6× 60 1.1× 37 0.8× 96 2.5× 11 348
Erin Zagadailov United States 12 100 1.4× 76 1.1× 24 0.4× 32 0.7× 21 0.5× 31 336
Susan Jin United States 7 73 1.0× 17 0.3× 63 1.2× 41 0.9× 37 0.9× 11 267
Nicole Wong Doo Australia 10 124 1.7× 28 0.4× 65 1.2× 7 0.2× 13 0.3× 29 317
David Tyas United Kingdom 8 81 1.1× 212 3.1× 49 0.9× 148 3.4× 16 0.4× 17 375

Countries citing papers authored by Anastassia Negrouk

Since Specialization
Citations

This map shows the geographic impact of Anastassia Negrouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastassia Negrouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastassia Negrouk more than expected).

Fields of papers citing papers by Anastassia Negrouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastassia Negrouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastassia Negrouk. The network helps show where Anastassia Negrouk may publish in the future.

Co-authorship network of co-authors of Anastassia Negrouk

This figure shows the co-authorship network connecting the top 25 collaborators of Anastassia Negrouk. A scholar is included among the top collaborators of Anastassia Negrouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastassia Negrouk. Anastassia Negrouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Borry, Pascal, et al.. (2022). Rethinking informed consent in the time of COVID-19: An exploratory survey. Frontiers in Medicine. 9. 995688–995688. 6 indexed citations
3.
Valcke, Peggy, et al.. (2022). Challenges related to data protection in clinical research before and during the COVID-19 pandemic: An exploratory study. Frontiers in Medicine. 9. 995689–995689. 9 indexed citations
4.
Negrouk, Anastassia, et al.. (2020). Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality. Frontiers in Medicine. 7. 585722–585722. 5 indexed citations
5.
Stahel, Rolf A., Denis Lacombe, Fátima Cardoso, et al.. (2020). Current models, challenges and best practices for work conducted between European academic cooperative groups and industry. ESMO Open. 5(2). e000628–e000628. 2 indexed citations
6.
Lacombe, Denis, Vassilis Golfinopoulos, Anastassia Negrouk, & Bertrand Tombal. (2020). Clinical research in Europe: Who do we do all that for?. Journal of Cancer Policy. 23. 100217–100217. 6 indexed citations
7.
Bagnoli, Marina, Tingyan Shi, Charlie Gourley, et al.. (2019). Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions. Cells. 8(3). 200–200. 6 indexed citations
8.
Negrouk, Anastassia & Denis Lacombe. (2018). Does GDPR harm or benefit research participants? An EORTC point of view. The Lancet Oncology. 19(10). 1278–1280. 13 indexed citations
9.
Negrouk, Anastassia, Denis Lacombe, Fátima Cardoso, et al.. (2017). Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. ESMO Open. 2(3). e000187–e000187. 9 indexed citations
10.
Horgan, Denis, et al.. (2017). Making Change Happen in Health. PubMed. 2(Suppl. 1). 1–8.
11.
Law, Kate, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. ed20–ed20. 6 indexed citations
12.
Kataoka, Kozo, Kenichi Nakamura, Carmela Caballero, et al.. (2016). Collaboration between EORTC and JCOG—how to accelerate global clinical research partnership. Japanese Journal of Clinical Oncology. 47(2). 164–169. 6 indexed citations
13.
Schneider, Daniel J., Peter Riegman, Maureen Cronin, et al.. (2016). Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks. Public Health Genomics. 19(3). 160–169. 5 indexed citations
15.
Negrouk, Anastassia, Denis Horgan, Alessandra Gorini, et al.. (2015). Clinical Trials, Data Protection and Patient Empowerment in the Era of the New EU Regulations. Public Health Genomics. 18(6). 386–395. 9 indexed citations
16.
Shash, Emad, Anastassia Negrouk, Sandrine Marréaud, et al.. (2013). International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective. ecancermedicalscience. 7. 321–321. 3 indexed citations
17.
Law, Kate, et al.. (2013). International Rare Cancers Initiative. The Lancet Oncology. 14(2). 109–110. 37 indexed citations
18.
Lacombe, Denis, Anastassia Negrouk, & John P. Bean. (2011). International investigator-driven clinical trials: challenges and opportunities for US–Europe cooperation through the US cooperative group networks. Clinical Investigation. 1(4). 493–500. 3 indexed citations
19.
20.
Meunier, Françoise, et al.. (2003). Throwing a wrench in the works?. The Lancet Oncology. 4(12). 717–718. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026